|
Jul 31
|
Stifel Holds the Line on NOV: Buy Rating Reaffirmed Despite Target Trim to $22
|
|
Jul 30
|
Here’s What Affected NOV’s (NOV) Sales and Profitability
|
|
Jul 30
|
NOV Q2 Earnings Miss, Revenues Beat Estimates, Both Decrease Y/Y
|
|
Jul 30
|
NOV Inc (NOV) Q2 2025 Earnings Call Highlights: Navigating Market Challenges with Strategic ...
|
|
Jul 28
|
Here's What Key Metrics Tell Us About Nov Inc. (NOV) Q2 Earnings
|
|
Jul 28
|
Nov Inc. (NOV) Q2 Earnings Miss Estimates
|
|
Jul 28
|
Nov Inc.: Q2 Earnings Snapshot
|
|
Jul 28
|
NOV Reports Second Quarter 2025 Results
|
|
Jul 24
|
Oil States International (OIS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Jul 23
|
Factors You Need to Know Ahead of NOV's Q2 Earnings Release
|
|
Jul 21
|
Earnings Preview: Nov Inc. (NOV) Q2 Earnings Expected to Decline
|
|
Jun 27
|
NOV Announces Second Quarter 2025 Earnings Conference Call
|
|
May 2
|
NOV Inc. Just Missed EPS By 23%: Here's What Analysts Think Will Happen Next
|
|
May 1
|
NOV Inc. price target lowered to $17 from $20 at JPMorgan
|
|
Feb 26
|
What Eli Lilly's $27B investment in US manufacturing means for GLP-1s
|
|
Feb 16
|
NOV Full Year 2024 Earnings: EPS Beats Expectations
|